Evolution of the Average Target: Harmonic Inc.

Evolution of the Average Target - Harmonic Inc.

Evolution of the Target Price: Harmonic Inc.

Evolution of the Target Price - Harmonic Inc.

Changes in Analyst Recommendations: Harmonic Inc.

9da3befaa546e6c7e305a981bf.2faIHx0TeqWunIxdyhfvCiCZb1x91FHC0oUtTvH885k.vJ7cd3h7NvqW1rgIqW6fR1PvPjs5sjOqt-Z8JYiUtPDtwuJ-VCEU0MLrwQ~319009247706115cdfe84a9634159a19
01-15 Top Midday Stories: BlackRock Rises on Q4 Results; Amazon Challenges Saks Global Chapter 11 Plan; Ford-BYD Potential Deal MT
25-07-28 Harmonic Q2 revenue, adjusted EPS beat expectations RE
25-07-08 Wolfe Initiates Harmonic at Underperform With $7 Price Target MT
25-01-10 Barclays Downgrades Harmonic to Equalweight From Overweight, Adjusts Price Target to $14 From $17 MT
25-01-09 Barclays Downgrades Harmonic to Equalweight From Overweight, Adjusts Price Target to $14 From $17 MT
24-10-29 Jefferies Downgrades Harmonic to Hold From Buy, Price Target is $12.50 MT
24-10-29 Raymond James Downgrades Harmonic to Outperform From Strong Buy, Price Target is $14 MT
24-01-30 Raymond James Trims Price Target on Harmonic to $18 From $19, Maintains Strong Buy Rating MT
24-01-30 Rosenblatt Securities Cuts Harmonic Price Target to $16 From $18, Maintains Buy Rating MT
23-11-01 Barclays Adjusts Price Target on Harmonic to $14 From $20, Maintains Overweight Rating MT
23-08-10 Raymond James Upgrades Harmonic to Strong Buy From Outperform, Adjusts Price Target to $16 From $15 MT
23-08-01 Jefferies Adjusts Harmonic Price Target to $18 From $19, Maintains Buy Rating MT
23-08-01 Raymond James Adjusts Price Target on Harmonic to $15 From $17, Maintains Outperform Rating MT
23-08-01 Rosenblatt Securities Adjusts Harmonic Price Target to $18 From $22, Maintains Buy Rating MT
23-08-01 Needham Adjusts Harmonic's Price Target to $18 From $21, Keeps Buy Rating MT
23-08-01 Barclays Adjusts Harmonic's Price Target to $20 From $23, Keeps Overweight Rating MT
23-05-09 Rosenblatt Adjusts Price Target on Harmonic to $22 From $20, Maintains Buy Rating MT
23-05-09 Barclays Adjusts Price Target on Harmonic to $23 From $20, Keeps Overweight Rating MT
23-03-21 Northland Securities Adjusts Price Target on Harmonic to $23 From $20, Keeps Outperform Rating MT
23-01-31 Raymond James Adjusts Harmonic Price Target to $17 From $18, Maintains Outperform Rating MT
23-01-31 Barclays Adjusts Harmonic's Price Target to $20 From $17, Keeps Overweight Rating MT
23-01-24 Needham Adjusts Price Target on Harmonic to $19 From $17, Maintains Buy Rating MT
23-01-09 Jefferies Upgrades Harmonic to Buy From Hold, Price Target is $19 MT
22-12-16 LifeSci Capital Downgrades Third Harmonic Bio to Market Perform From Outperform MT
22-12-16 Morgan Stanley Downgrades Third Harmonic Bio to Equalweight From Overweight, Slashes Price Target to $5 From $34 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+63.96%
+43.98%
+48.94%
+123.03%
+5.36%
+209.03%
+11.55%
+18.35%
+131.2%
+63.43%
Average +71.88%
Weighted average by Cap. +63.12%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
9.410USD
Average target price
15.43USD
Spread / Average Target
+63.96%
High Price Target
20.00USD
Spread / Highest target
+112.54%
Low Price Target
9.000USD
Spread / Lowest Target
-4.36%

Analyst Consensus Detail

Analyst consensus - Harmonic Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Harmonic Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Harmonic Inc.
  1. Stock Market
  2. Stocks
  3. HLIT Stock
  4. Consensus Harmonic Inc.